Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Spectrum Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 11
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 14
Partnerships 14
myTomorrows Enters into Agreement with Spectrum Pharma 14
Spectrum Pharma Enters into Agreement with Servier Canada 15
Eagle Pharma Enters into Agreement with Spectrum Pharma 16
Licensing Agreements 17
Spectrum Pharma Enters into Licensing Agreement with University of Texas MD Anderson Cancer 17
Mundipharma Enters into Licensing Agreement with Spectrum Pharma for Zevalin 18
Spectrum Pharma Enters into Licensing Agreement with Hanmi Pharma for Poziotinib 20
Spectrum Pharma Enters into Licensing Agreement with CASI for Zevalin, Marqibo and Captisol-Enabled Melphalan 21
Dr. Reddy Labs Enters into Licensing Agreement with Spectrum Pharma 23
Ligand Pharma Enters Into Licensing Agreement With Spectrum Pharma For Captisol-Enabled Melphalan 24
Spectrum Pharma Amends Licensing Agreement With Allergan For Apaziquone 26
Spectrum Pharma Enters Into Licensing Agreement With Bayer Healthcare For Zevalin 27
Spectrum Pharma Enters Into Licensing Agreement With Hanmi Pharma For SPI-2012 28
Spectrum Pharma Amends Licensing Agreement With TopoTarget For Belinostat 29
Equity Offering 30
Spectrum Pharma Raises USD90.2 Million in Private Placement of Shares 30
Spectrum Pharma Raises USD3 Million in Private Placement of Shares 32
Spectrum Pharma to Raise USD100 Million in Public Offeirng of Shares 33
Talon Therapeutics Completes Private Placement Of Preferred Stock For US$11 Million 34
Debt Offering 36
Spectrum Pharma Completes Private Placement Of Notes Due 2018 For US$100 Million 36
Acquisition 38
Spectrum Pharmaceuticals May Sell Itself 38
Spectrum Pharma Acquires Majority Stake In Talon Therapeutics 39
Spectrum Pharma Completes Acquisition Of Allos Therapeutics For USD206 Million 41
Spectrum Pharmaceuticals Inc – Key Competitors 43
Spectrum Pharmaceuticals Inc – Key Employees 44
Spectrum Pharmaceuticals Inc – Locations And Subsidiaries 45
Head Office 45
Other Locations & Subsidiaries 45
Joint Venture 46
Recent Developments 47
Financial Announcements 47
Aug 09, 2018: Spectrum Pharmaceuticals reports second quarter 2018 financial results and pipeline update 47
May 03, 2018: Spectrum Pharmaceuticals Reports First Quarter 2018 Financial Results and Pipeline Update 49
Mar 06, 2018: Spectrum Pharmaceuticals Reports Fourth Quarter 2017 and Full Year 2017 Financial Results and Pipeline Update 51
Nov 02, 2017: Spectrum Pharmaceuticals Reports Third Quarter 2017 Financial Results and Pipeline Update 53
Aug 03, 2017: Spectrum Pharmaceuticals Reports Second Quarter 2017 Financial Results and Pipeline Update 55
May 02, 2017: Spectrum Pharmaceuticals Reports First Quarter 2017 Financial Results and Pipeline Update 56
Mar 08, 2017: Spectrum Pharmaceuticals Reports Fourth Quarter 2016 and Full Year 2016 Financial Results and Pipeline Update 57
Corporate Communications 59
Oct 18, 2018: Spectrum Pharmaceuticals names Dr. Francois Lebel as chief medical officer 59
Feb 27, 2018: Spectrum Pharmaceuticals Announces Appointment of William L. Ashton to its Board of Directors 60
Dec 17, 2017: Spectrum Pharmaceuticals Announces Leadership Changes 61
Product News 62
12/04/2017: Spectrum Pharmaceuticals To Present Abstracts On MARQIBO At The 59th Annual Meeting Of The ASH in Atlanta, Georgia, December 9-12, 2017 62
06/02/2017: Spectrum Pharmaceuticals Announces Presentation on MARQIBO at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, June 2-6, 2017 63
06/02/2017: Spectrum Pharmaceuticals Highlights Clinical Data on FOLOTYN at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, June 2-6, 2017 64
Product Approvals 65
Sep 07, 2017: CASI Provides Update on MARQIBO 65
Clinical Trials 66
Jun 19, 2017: Spectrum Pharmaceuticals Highlights Results of a Combination Study of FOLOTYN Plus Romidepsin Presented at the 14th International Conference on Malignant Lymphoma (14-ICML) Meeting 66
Other Significant Developments 67
Apr 30, 2018: Spectrum Pharmaceuticals announces corporate governance enhancements and board changes 67
Apr 27, 2018: Company Profile for Spectrum Pharmaceuticals 68
Mar 07, 2018: Spectrum Pharmaceuticals to present corporate update at the Cowen and Company 38th annual health care conference on March 13th 69
Appendix 70
Methodology 70
About GlobalData 70
Contact Us 70
Disclaimer 70
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Spectrum Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Spectrum Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 11
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
myTomorrows Enters into Agreement with Spectrum Pharma 14
Spectrum Pharma Enters into Agreement with Servier Canada 15
Eagle Pharma Enters into Agreement with Spectrum Pharma 16
Spectrum Pharma Enters into Licensing Agreement with University of Texas MD Anderson Cancer 17
Mundipharma Enters into Licensing Agreement with Spectrum Pharma for Zevalin 18
Spectrum Pharma Enters into Licensing Agreement with Hanmi Pharma for Poziotinib 20
Spectrum Pharma Enters into Licensing Agreement with CASI for Zevalin, Marqibo and Captisol-Enabled Melphalan 21
Dr. Reddy Labs Enters into Licensing Agreement with Spectrum Pharma 23
Ligand Pharma Enters Into Licensing Agreement With Spectrum Pharma For Captisol-Enabled Melphalan 24
Spectrum Pharma Amends Licensing Agreement With Allergan For Apaziquone 26
Spectrum Pharma Enters Into Licensing Agreement With Bayer Healthcare For Zevalin 27
Spectrum Pharma Enters Into Licensing Agreement With Hanmi Pharma For SPI-2012 28
Spectrum Pharma Amends Licensing Agreement With TopoTarget For Belinostat 29
Spectrum Pharma Raises USD90.2 Million in Private Placement of Shares 30
Spectrum Pharma Raises USD3 Million in Private Placement of Shares 32
Spectrum Pharma to Raise USD100 Million in Public Offeirng of Shares 33
Talon Therapeutics Completes Private Placement Of Preferred Stock For US$11 Million 34
Spectrum Pharma Completes Private Placement Of Notes Due 2018 For US$100 Million 36
Spectrum Pharmaceuticals May Sell Itself 38
Spectrum Pharma Acquires Majority Stake In Talon Therapeutics 39
Spectrum Pharma Completes Acquisition Of Allos Therapeutics For USD206 Million 41
Spectrum Pharmaceuticals Inc, Key Competitors 43
Spectrum Pharmaceuticals Inc, Key Employees 44
Spectrum Pharmaceuticals Inc, Other Locations 45
Spectrum Pharmaceuticals Inc, Subsidiaries 45
Spectrum Pharmaceuticals Inc, Joint Venture 46
List of Figures
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Spectrum Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 11